American Podiatric Medical Licensing Examination (APMLE) Part 1 Practice Test 2026 - Free APMLE Part 1 Practice Questions and Study Guide

Session length

1 / 20

Which antidote reactivates acetylcholinesterase inhibited by organophosphates?

Diazepam

Pralidoxime

Organophosphate poisoning inhibits acetylcholinesterase by phosphorylating the enzyme’s active site, causing a buildup of acetylcholine and overstimulation of cholinergic receptors. The antidote that can actually restore enzyme activity is pralidoxime, an oxime that cleaves the phosphate from the enzyme, reactivating acetylcholinesterase. This reactivation is most effective before the enzyme–phosphate complex ages, after which reactivation fails. Pralidoxime is used alongside atropine to address both nicotinic and muscarinic symptoms, but atropine alone doesn’t restore AChE function. Diazepam helps control seizures but doesn’t reverse enzyme inhibition, and epinephrine is a vasopressor rather than a specific antidote.

Atropine

Epinephrine

Next question

Find the option that is right for you!

All options are one-time payments.

$12.50

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
👑$30.00 $87.50 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $87.50 usd value for $30.00! You save $57.50!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$12.50 $18.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy